Evidence map›Paper›PMID 38149270›Full record

ReviewFrontiers in microbiology2023

MRI advances in the imaging diagnosis of tuberculous meningitis: opportunities and innovations.

Xingyu Chen, Fanxuan Chen, Chenglong Liang, Guoqiang He, Hao Chen, Yanchan Wu, Yinda Chen, Jincen Shuai, Yilei Yang, Chenyue Dai and 13 more

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 7 institutions in 2 countries.

Xingyu Chen *Department of Infectious Diseases, Wenzhou Central Hospital, Wenzhou, China.
Fanxuan Chen *School of Biomedical Engineering, School of Ophthalmology and Optometry, Eye Hospital, Wenzhou Medical University, Wenzhou, China.
Chenglong Liang *The First School of Medicine, Wenzhou Medical University, Wenzhou, China.
Guoqiang He *Postgraduate Training Base Alliance of Wenzhou Medical University, Wenzhou, China.
Hao Chen *The First School of Medicine, Wenzhou Medical University, Wenzhou, China.
Yanchan WuSchool of Electrical and Information Engineering, Quzhou University, Quzhou, China.
Yinda ChenSchool of Electrical and Information Engineering, Quzhou University, Quzhou, China.
Jincen ShuaiBaskin Engineering, University of California, Santa Cruz, CA, United States.
Yilei YangThe First School of Medicine, Wenzhou Medical University, Wenzhou, China.
Chenyue DaiWenzhou Medical University, Wenzhou, China.
Luhuan CaoWenzhou Medical University, Wenzhou, China.
Xian WangWenzhou Medical University, Wenzhou, China.
Enna CaiWenzhou Medical University, Wenzhou, China.
Jiamin WangWenzhou Medical University, Wenzhou, China.
Mengjing WuWenzhou Medical University, Wenzhou, China.
Li ZengWenzhou Medical University, Wenzhou, China.
Jiaqian ZhuWenzhou Medical University, Wenzhou, China.
Darong HaiWenzhou Medical University, Wenzhou, China.
Wangzheng PanRenji College of Wenzhou Medical University, Wenzhou, China.
Shuo PanThe First School of Medicine, Wenzhou Medical University, Wenzhou, China.
Chengxi ZhangSchool of Materials Science and Engineering, Shandong Jianzhu University, Jinan, China.
Shichao QuanDepartment of Big Data in Health Science, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Feifei SuDepartment of Infectious Diseases, Wenzhou Central Hospital, Wenzhou, China.
Wenzhou Medical University · CNQuzhou University · CNAffiliated Eye Hospital of Wenzhou Medical College · CNShandong Jianzhu University · CNUniversity of California, Santa Cruz · USUniversity of Chinese Academy of Sciences · CNWenzhou Central Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tuberculous meningitis (TBM) is not only one of the most fatal forms of tuberculosis, but also a major public health concern worldwide, presenting grave clinical challenges due to its nonspecific symptoms and the urgent need for timely intervention. The severity and the rapid progression of TBM underscore the necessity of early and accurate diagnosis to prevent irreversible neurological deficits and reduce mortality rates. Traditional diagnostic methods, reliant primarily on clinical findings and cerebrospinal fluid analysis, often falter in delivering timely and conclusive results. Moreover, such methods struggle to distinguish TBM from other forms of neuroinfections, making it critical to seek advanced diagnostic solutions. Against this backdrop, magnetic resonance imaging (MRI) has emerged as an indispensable modality in diagnostics, owing to its unique advantages. This review provides an overview of the advancements in MRI technology, specifically emphasizing its crucial applications in the early detection and identification of complex pathological changes in TBM. The integration of artificial intelligence (AI) has further enhanced the transformative impact of MRI on TBM diagnostic imaging. When these cutting-edge technologies synergize with deep learning algorithms, they substantially improve diagnostic precision and efficiency. Currently, the field of TBM imaging diagnosis is undergoing a phase of technological amalgamation. The melding of MRI and AI technologies unquestionably signals new opportunities in this specialized area.

Indexed as

artificial intelligencemachine learningMRIMycobacterium tuberculosisneurological infectionstuberculous meningitis

Identifiers

PMID38149270
PMCPMC10750405
OpenAlexW4389599758

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.